Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Weight Loss × Exenatide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 6 Obesity 5 Sexual Infantilism 4 Craniopharyngioma 3 Pancreatic Neoplasms 2 Overweight 2 Weight Loss 1 Insulin Resistance 1 Fatty Liver 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus, Type 1 1

Interventions

Exercise 7 Caloric Restriction 5 Metformin 4 Diet 4 Octreotide 3 Nutrition Assessment 3 anamorelin 2 Standard of Care 2 Megestrol Acetate 2 Liraglutide 2 Diet, Carbohydrate-Restricted 2 Diet Therapy 2 Cognitive Behavioral Therapy 2 sibutramine 1 remune 1 olanzapine-fluoxetine combination 1 lime 1 irinotecan sucrosofate 1 bermekimab 1 Weight Reduction Programs 1 Urine Specimen Collection 1 Tirzepatide 1 Surveys and Questionnaires 1 Sugars 1 Sampling Studies 1 Ritonavir 1 Resistance Training 1 Quality of Life 1 Psychology, Positive 1 Population Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02664441 2022-05-05

ECHO

Seattle Children's Hospital

Phase 3 Completed

42 enrolled 26 charts

Obesity, Weight Loss, Sexual Infantilism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡